Skip to main content
Rural Health Information Hub
Rural Health Information Hub

DEA, HHS: Expansion of Buprenorphine Treatment via Telemedicine Encounter

Source
Federal Register
Link
View Full Story
Date
Jan 17, 2025
Summary
Notice of final rule from the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) amending their regulations to increase access to buprenorphine treatment for opioid use disorders (OUD) through a telemedicine encounter. This rule expands the circumstances under which individual providers are authorized to prescribe buprenorphine for OUD via telemedicine, including an audio-only telemedicine encounter. This final rule is effective February 18, 2025.
Tagged as
Access · Illicit drug use · Legislation and regulations · Pharmacy and prescription drugs · Prescription drug misuse · Telehealth